Results 111 to 120 of about 9,132 (175)

Urinary nephrin as an early biomarker of podocyte dysfunction in essential hypertension: a stage-stratified study from Bukhara, Uzbekistan. [PDF]

Front Cardiovasc Med
Amonov MKO.
europepmc   +1 more source

Mineralocorticoid receptor antagonists: Efficacy and safety in chronic kidney disease. [PDF]

Diabetes Obes Metab
Mottl AK, Khunti K, Mathieu C.
europepmc   +1 more source

Comparative safety profiles of spironolactone, eplerenone, and finerenone: a pharmacovigilance study based on FAERS data from 2004 to 2024. [PDF]

Front Pharmacol
Ji K, Huang X, Wang F, Zhang L, Zheng Y, Ji L, Ju Y, Zhuang X, Li J.   +8 more
europepmc   +1 more source

Real-World Utilisation and Cost Trends of Mineralocorticoid Receptor Antagonists in England: A Population-Level Prescribing Analysis From 2022 to 2025. [PDF]

Cardiovasc Ther
Kow CS, Hasan SS, Thiruchelvam K, Zaihan AF.   +3 more
europepmc   +1 more source

Perioperative management of patients with primary aldosteronism: a practical approach for the endocrinologist. [PDF]

Endocr Connect
da Cunha Brito P, de Sousa Lages A, Machado C, Fernandes V.   +3 more
europepmc   +1 more source

Abnormal activation of the mineralocorticoid receptor in the aldosterone-sensitive distal nephron contributes to fructose-induced salt-sensitive hypertension. [PDF]

Am J Physiol Renal Physiol
Zhang R, Kim N, Shi S, Jadhav DA, Brostek A, Forester BR, Shukla R, Qu C, Kramer BK, Moss FJ, Garvin JL, Kleyman TR, Gonzalez-Vicente A.   +12 more
europepmc   +1 more source

Spironolactone-Induced Bilateral Gynecomastia in a Patient With Comorbid Conditions. [PDF]

Cureus
Brahmbhatt SV, Jain D.
europepmc   +1 more source

Residual risk in cardiovascular and renal diseases and the potential role of aldosterone synthase inhibitors. [PDF]

Front Cardiovasc Med
Umanath K, Dwyer JP, Mentz RJ.
europepmc   +1 more source

The Role of Aldosterone in Vascular Permeability in Diabetes. [PDF]

Cells
Aleksiejczuk M, Bielicka N, Bruzgo-Grzybko M, Kalita IS, Olichwier AJ, Mierzejewska P, Stelmaszewska J, Dzieciol J, Chabielska E, Gromotowicz-Poplawska A.   +9 more
europepmc   +1 more source

Drug-Resistant Sinus Tachycardia as a Dose-Dependent Side Effect of Spironolactone: A Case Report and Review of the Literature. [PDF]

Clin Case Rep
Abdi Z, Chenaghlou M, Rezabakhsh A, Hooshmand Gharabagh L.   +3 more
europepmc   +1 more source